Upstream Bio (UPB) Depreciation & Amortization (CF) (2023 - 2026)
Upstream Bio's (UPB) quarterly Depreciation & Amortization (CF) came in at $49000.0 in Q1 2026, up 13.95% year-on-year from $43000.0 in Q1 2025, and down 14.04% quarter-over-quarter from $57000.0 in Q4 2025.
Upstream Bio (UPB) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Upstream Bio's Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at $49000.0 for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 13.95% year-over-year to $49000.0 in Q1 2026; TTM through Mar 2026 was $306000.0, a 4.79% increase from a year earlier, with the FY2025 full-year figure at $188000.0, up 111.24% from the prior year.
- Depreciation & Amortization (CF) slipped to $49000.0 in Q1 2026 per UPB's latest filing, from $57000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $100000.0 in Q3 2023 and bottomed at $13000.0 in Q1 2024.
- The 4-year median for Depreciation & Amortization (CF) is $57000.0 (2025), against an average of $65909.1.
- Biggest YoY gain for Depreciation & Amortization (CF) was 250.0% in 2024; the steepest drop was 0.0% in 2024.
- Year by year, Depreciation & Amortization (CF) stood at $14000.0 in 2023, then surged by 250.0% to $49000.0 in 2024, then climbed by 16.33% to $57000.0 in 2025, then slipped by 14.04% to $49000.0 in 2026.
- Per Business Quant, the three latest UPB Depreciation & Amortization (CF) figures stand at $49000.0 (Q1 2026), $57000.0 (Q4 2025), and $100000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 41.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Upstream Bio | 343.65 Mn | 343.65 Mn | -3.94 Mn | 49,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49,000.00 |
| Mar 31, 2026 | 49,000.00 |
| Dec 31, 2025 | 57,000.00 |
| Dec 31, 2025 | 57,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Dec 31, 2023 | 14,000.00 |